Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Calvin C. Willhite, Gwendolyn L. Ball & Clifton J. McLellan. (2012) Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water. Critical Reviews in Toxicology 42:5, pages 358-442.
Read now
Read now
Daniel Krewski, RobertA Yokel, Evert Nieboer, David Borchelt, Joshua Cohen, Jean Harry, Sam Kacew, Joan Lindsay, AmalM Mahfouz & Virginie Rondeau. (2007) Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide. Journal of Toxicology and Environmental Health, Part B 10:sup1, pages 1-269.
Read now
Read now
I. N. Marks. (1991) Sucralfate—Safety and Side Effects. Scandinavian Journal of Gastroenterology 26:sup185, pages 36-42.
Read now
Read now
Articles from other publishers (27)
F. Paquet, R.W. Leggett, E. Blanchardon, M.R. Bailey, D. Gregoratto, T. Smith, G. Ratia, E. Davesne, V. Berkovski & J.D. Harrison. (2022) ICRP Publication 151: Occupational Intakes of Radionuclides: Part 5. Annals of the ICRP 51:1-2, pages 11-415.
Crossref
Crossref
Gordon L. Klein. (2019) Aluminum toxicity to bone: A multisystem effect?. Osteoporosis and Sarcopenia 5:1, pages 2-5.
Crossref
Crossref
Brian A Hemstreet. (2016) Use of Sucralfate in Renal Failure. Annals of Pharmacotherapy 35:3, pages 360-364.
Crossref
Crossref
Marika Kamberi, Hajime Nakashima, Keita Ogawa, Naomi Oda & Shigeyuki Nakano. (2000) The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin. British Journal of Clinical Pharmacology 49:2, pages 98-103.
Crossref
Crossref
K Walton, R Walker, J.J.M van de Sandt, J.V Castell, A.G.A.A Knapp, G Kozianowski, M Roberfroid & B Schilter. (1999) The application of in vitro data in the derivation of the Acceptable Daily Intake of food additives. Food and Chemical Toxicology 37:12, pages 1175-1197.
Crossref
Crossref
Marie L. Borum. (1999) Peptic-Ulcer Disease in the Elderly. Clinics in Geriatric Medicine 15:3, pages 457-471.
Crossref
Crossref
N. D. Priest, R. J. Talbot, J. G. Austin, J. P. Day, S. J. King, K. Fifield & R. G. Cresswell. (1996) The bioavailability of26Al-labelled aluminium citrate and aluminium hydroxide in volunteers. BioMetals 9:3, pages 221-228.
Crossref
Crossref
Guy Berthon. (1996) Chemical speciation studies in relation to aluminium metabolism and toxicity. Coordination Chemistry Reviews 149, pages 241-280.
Crossref
Crossref
Olivier Guillard, François Huguet, Bernard Fauconneau, Alain Piriou & Alain Pineau. (1996) Absence of Gastrointestinal Absorption or Urinary Excretion of Aluminium from an Allantoinate Complex Contained in Two Antacid Formulations in Patients with Normal Renal Function. Clinical Chemistry and Laboratory Medicine 34:8.
Crossref
Crossref
David R. Mathews & Nicola G. Dahl. 1995. Sucralfate. Sucralfate
215
224
.
E. L. Conway, C. O'Callaghan, O. H. Drummer, L. G. Howes & W. J. Louis. (2006) A single‐dose comparison of the bioavailabilty of aluminium from two formulations of sucralphate in normal volunteers. Biopharmaceutics & Drug Disposition 15:3, pages 253-261.
Crossref
Crossref
S. L. Rifat & M. R. Eastwood. 1994. Dementia. Dementia
267
280
.
J. J. Powell & R. P. H. Thompson. (2007) The chemistry of aluminium in the gastrointestinal lumen and its uptake and absorption. Proceedings of the Nutrition Society 52:1, pages 241-253.
Crossref
Crossref
Kent D. Katz & Daniel Hollander. (1992) Practical pharmacology and cost-effective management of peptic ulcer disease. The American Journal of Surgery 163:3, pages 349-359.
Crossref
Crossref
Ami D. Sperber, Yaakov Henkin, Irene Zuili, Jacob E. Bearman & Shraga Shany. (1991) The hypocholesterolemic effect of an antacid containing aluminum hydroxide. The American Journal of Medicine 91:6, pages 597-604.
Crossref
Crossref
Jadwiga Chmielnicka & Marzenna Nasiadek. (1991) Tissue distribution and urinary excretion of essential elements in rats orally exposed to aluminum chloride. Biological Trace Element Research 31:2, pages 131-138.
Crossref
Crossref
John A. Oates, Alastair J.J. Wood & Denis M. McCarthy. (1991) Sucralfate. New England Journal of Medicine 325:14, pages 1017-1025.
Crossref
Crossref
P. MISTRY, Z. VARGHESE & R. E. POUNDER. (2007) Short report: plasma aluminium concentration and 24‐hour urinary aluminium excretion before, during and after treatment with sucralfate. Alimentary Pharmacology & Therapeutics 5:5, pages 549-553.
Crossref
Crossref
H. Ott. (1991) Reply. Gut 32:6, pages 723-723.
Crossref
Crossref
M C Allison. (1991) Long-term maintenance therapy with sucralfate.. Gut 32:6, pages 723-723.
Crossref
Crossref
S N Gyde. (1991) Reply. Gut 32:6, pages 723-723.
Crossref
Crossref
J E Lennard-Jones. (1991) Letters to the editor. Gut 32:6, pages 722-723.
Crossref
Crossref
T.H. ITTEL, U. GLADZIWA, W. MÜCK & H.G. SIEBERTH. (1991) Hyperaluminaemia in critically ill patients: role of antacid therapy and impaired renal function. European Journal of Clinical Investigation 21:1, pages 96-102.
Crossref
Crossref
J C GarreltsP J GodleyJ D PeterieE H GerlachC C Yakshe. (1990) Sucralfate significantly reduces ciprofloxacin concentrations in serum. Antimicrobial Agents and Chemotherapy 34:5, pages 931-933.
Crossref
Crossref
P Allain, Y Mauras, N Krari, J Duchier, A Cournot & J Larcheveque. (2012) Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate [see comments]. British Journal of Clinical Pharmacology 29:4, pages 391-395.
Crossref
Crossref
Michael Wilhelm, Daphne E. Jäger & Friedrich K. Ohnesorge. (1990) Aluminium Toxicokinetics. Pharmacology & Toxicology 66:1, pages 4-9.
Crossref
Crossref
Clifford Tasman-Jones, Gail Morrison, Lindy Thomsen & Mark Vanderwee. (1989) Sucralfate interactions with gastric mucus. The American Journal of Medicine 86:6, pages 5-9.
Crossref
Crossref